Addressing and managing erectile dysfunction after prostatectomy for prostate cancer

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Erectile dysfunction (ED) is a frequent complication following radical prostatectomy.
• Available treatments for post-prostatectomy ED include oral phosphodiesterase type 5 inhibitors, constriction devices, intraurethral suppositories, penile injections, and penile prostheses.
• Penile rehabilitation is essential to encourage spontaneous erectile function recovery.

Purpose of the Study:

• To outline the five categories of ED treatments available for men after radical prostatectomy.
• To highlight the importance of comprehensive patient education on the pros and cons of each treatment.
• To emphasize the role of early intervention and penile rehabilitation in managing post-prostatectomy ED.

Main Methods:

• Review of current treatment modalities for erectile dysfunction post-prostatectomy.
• Categorization of treatments into oral agents, noninvasive devices, intraurethral suppositories, injections, and surgical implants.
• Discussion of the role of these treatments in penile rehabilitation.

Main Results:

• Oral phosphodiesterase type 5 inhibitors are common but not always effective.
• Noninvasive options include venous constriction bands and vacuum devices.
• Intraurethral suppositories (MUSE), injections, and penile prostheses offer alternative solutions.
• Penile rehabilitation using various methods shows varied success rates.
• Untreated ED can lead to penile atrophy.

Conclusions:

• Comprehensive information on all ED treatment options and their penile rehabilitation potential is vital.
• Informed patient choices regarding early intervention can improve outcomes for post-prostatectomy erectile dysfunction.
• Addressing ED promptly is critical to prevent complications like penile atrophy.